MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced a live webcast with Maria Maccecchini, Ph.D., President and CEO, to provide updates and answer audience questions.
Webcast Details
- Date: June 24, 2025
- Time: 4:30 PM EDT
- Registration: Click here to register
Dr. Maccecchini will discuss progress on the pivotal Phase 3 trial in early AD, the FDA’s feedback on the PD program, and other key updates. The event includes a brief presentation and live Q&A, giving attendees a chance to engage directly with the CEO.
The webcast is open to shareholders, patients, investigators, and anyone interested in Annovis’ work and direction. Submit questions in advance by emailing ir@annovisbio.com.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.